Ki-67 staining index as a marker of proliferation and use as a biomarker has demonstrated impressive independent prognostic ability in definitive cases of prostate cancer as described above and is a logical molecular biomarker candidate in the salvage setting. This evidence concerns the gene MKI67 and prostate carcinoma.